Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surgical Wound Infection | 4 | 2021 | 264 | 1.230 |
Why?
|
| Lower Extremity | 4 | 2021 | 183 | 1.040 |
Why?
|
| Surgical Procedures, Operative | 3 | 2025 | 226 | 1.030 |
Why?
|
| Femoral Artery | 2 | 2020 | 136 | 0.990 |
Why?
|
| Peripheral Arterial Disease | 4 | 2020 | 318 | 0.820 |
Why?
|
| Arteriovenous Shunt, Surgical | 2 | 2013 | 89 | 0.700 |
Why?
|
| Vascular Grafting | 2 | 2021 | 48 | 0.640 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2020 | 905 | 0.600 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 139 | 0.580 |
Why?
|
| Arteries | 1 | 2019 | 208 | 0.560 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 226 | 0.540 |
Why?
|
| Diabetic Foot | 1 | 2020 | 168 | 0.540 |
Why?
|
| Workload | 1 | 2019 | 151 | 0.530 |
Why?
|
| Patient Participation | 1 | 2020 | 246 | 0.530 |
Why?
|
| Vascular Surgical Procedures | 3 | 2021 | 539 | 0.520 |
Why?
|
| Infection Control | 1 | 2018 | 161 | 0.490 |
Why?
|
| Self Report | 2 | 2019 | 557 | 0.490 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2025 | 845 | 0.480 |
Why?
|
| Postoperative Complications | 2 | 2025 | 3114 | 0.470 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 703 | 0.430 |
Why?
|
| Caregivers | 1 | 2020 | 572 | 0.430 |
Why?
|
| Stents | 1 | 2020 | 783 | 0.430 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1234 | 0.420 |
Why?
|
| Anti-Bacterial Agents | 3 | 2021 | 2551 | 0.400 |
Why?
|
| Femoral Vein | 1 | 2013 | 48 | 0.380 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 775 | 0.370 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 2099 | 0.360 |
Why?
|
| Iliac Artery | 1 | 2012 | 63 | 0.360 |
Why?
|
| Vena Cava, Inferior | 1 | 2012 | 95 | 0.350 |
Why?
|
| Adipogenesis | 1 | 2010 | 80 | 0.320 |
Why?
|
| Ischemia | 1 | 2013 | 354 | 0.310 |
Why?
|
| Limb Salvage | 2 | 2020 | 148 | 0.290 |
Why?
|
| Intermittent Claudication | 2 | 2019 | 49 | 0.290 |
Why?
|
| Renal Dialysis | 2 | 2013 | 950 | 0.290 |
Why?
|
| Internship and Residency | 1 | 2019 | 1216 | 0.280 |
Why?
|
| Aged | 9 | 2025 | 20926 | 0.270 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 456 | 0.270 |
Why?
|
| Middle Aged | 11 | 2025 | 28450 | 0.270 |
Why?
|
| Walking | 2 | 2019 | 214 | 0.260 |
Why?
|
| Energy Metabolism | 1 | 2010 | 796 | 0.230 |
Why?
|
| Female | 14 | 2025 | 70513 | 0.210 |
Why?
|
| Kidney Failure, Chronic | 1 | 2012 | 941 | 0.210 |
Why?
|
| Retrospective Studies | 6 | 2025 | 17655 | 0.210 |
Why?
|
| Risk Factors | 5 | 2025 | 10993 | 0.200 |
Why?
|
| Male | 12 | 2025 | 64560 | 0.200 |
Why?
|
| Humans | 18 | 2025 | 130573 | 0.170 |
Why?
|
| Comparative Effectiveness Research | 1 | 2020 | 71 | 0.160 |
Why?
|
| Vascular Patency | 1 | 2020 | 182 | 0.160 |
Why?
|
| Drug-Eluting Stents | 1 | 2020 | 63 | 0.160 |
Why?
|
| Metals | 1 | 2020 | 66 | 0.160 |
Why?
|
| Professional-Patient Relations | 1 | 2020 | 93 | 0.150 |
Why?
|
| Delay Discounting | 1 | 2019 | 7 | 0.150 |
Why?
|
| Economics, Behavioral | 1 | 2019 | 8 | 0.150 |
Why?
|
| Patient Compliance | 2 | 2019 | 468 | 0.150 |
Why?
|
| Health Services Research | 1 | 2020 | 178 | 0.150 |
Why?
|
| Organizational Policy | 1 | 2019 | 50 | 0.140 |
Why?
|
| Treatment Outcome | 4 | 2020 | 12891 | 0.140 |
Why?
|
| Prosthesis-Related Infections | 1 | 2021 | 184 | 0.140 |
Why?
|
| United States | 3 | 2025 | 11820 | 0.140 |
Why?
|
| Datasets as Topic | 1 | 2018 | 101 | 0.140 |
Why?
|
| Exercise Tolerance | 1 | 2018 | 89 | 0.140 |
Why?
|
| Health Resources | 1 | 2019 | 127 | 0.140 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2019 | 84 | 0.140 |
Why?
|
| Prosthesis Design | 1 | 2020 | 614 | 0.130 |
Why?
|
| Exercise Therapy | 1 | 2019 | 171 | 0.130 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2021 | 474 | 0.130 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 456 | 0.130 |
Why?
|
| Smoking Cessation | 1 | 2018 | 191 | 0.130 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 452 | 0.130 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2018 | 115 | 0.130 |
Why?
|
| Rectal Neoplasms | 1 | 2018 | 78 | 0.130 |
Why?
|
| Qualitative Research | 1 | 2020 | 698 | 0.120 |
Why?
|
| Communication | 1 | 2020 | 528 | 0.120 |
Why?
|
| Health Behavior | 1 | 2018 | 389 | 0.120 |
Why?
|
| Colonic Neoplasms | 1 | 2018 | 263 | 0.110 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2013 | 744 | 0.110 |
Why?
|
| Survival Rate | 1 | 2019 | 2136 | 0.110 |
Why?
|
| Ankle Brachial Index | 1 | 2013 | 41 | 0.100 |
Why?
|
| Bacillus | 1 | 2013 | 37 | 0.100 |
Why?
|
| Microbial Viability | 1 | 2013 | 43 | 0.100 |
Why?
|
| Time Factors | 2 | 2020 | 6223 | 0.100 |
Why?
|
| Ligation | 1 | 2013 | 133 | 0.100 |
Why?
|
| Saphenous Vein | 1 | 2013 | 50 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2020 | 3712 | 0.100 |
Why?
|
| Diabetic Angiopathies | 1 | 2013 | 67 | 0.090 |
Why?
|
| Albuminuria | 1 | 2013 | 105 | 0.090 |
Why?
|
| Exercise | 1 | 2018 | 866 | 0.090 |
Why?
|
| Upper Extremity Deep Vein Thrombosis | 1 | 2012 | 3 | 0.090 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 4033 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3413 | 0.090 |
Why?
|
| Diabetic Nephropathies | 1 | 2013 | 114 | 0.090 |
Why?
|
| Thrombophilia | 1 | 2012 | 41 | 0.090 |
Why?
|
| Activins | 1 | 2010 | 72 | 0.080 |
Why?
|
| Vascular Diseases | 1 | 2012 | 152 | 0.080 |
Why?
|
| Anemia, Sickle Cell | 1 | 2012 | 323 | 0.070 |
Why?
|
| Young Adult | 1 | 2019 | 9991 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 1423 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2022 | 328 | 0.040 |
Why?
|
| Polymethyl Methacrylate | 1 | 2021 | 13 | 0.040 |
Why?
|
| Veterans | 2 | 2024 | 1792 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2024 | 718 | 0.040 |
Why?
|
| Texas | 2 | 2019 | 3606 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2021 | 116 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 4663 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2021 | 350 | 0.040 |
Why?
|
| Healthy Lifestyle | 1 | 2018 | 33 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2010 | 4664 | 0.030 |
Why?
|
| Colon, Ascending | 1 | 2018 | 8 | 0.030 |
Why?
|
| Colon, Sigmoid | 1 | 2018 | 11 | 0.030 |
Why?
|
| Neomycin | 1 | 2018 | 36 | 0.030 |
Why?
|
| Veterans Health | 1 | 2019 | 171 | 0.030 |
Why?
|
| Cathartics | 1 | 2018 | 29 | 0.030 |
Why?
|
| Anastomotic Leak | 1 | 2018 | 36 | 0.030 |
Why?
|
| Citric Acid | 1 | 2018 | 46 | 0.030 |
Why?
|
| Health Surveys | 1 | 2018 | 261 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 3816 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 111 | 0.030 |
Why?
|
| Metronidazole | 1 | 2018 | 162 | 0.030 |
Why?
|
| Operative Time | 1 | 2018 | 207 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2018 | 195 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 698 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1165 | 0.030 |
Why?
|
| Spacecraft | 1 | 2013 | 2 | 0.030 |
Why?
|
| Mice | 1 | 2010 | 18222 | 0.030 |
Why?
|
| Spores, Bacterial | 1 | 2013 | 23 | 0.020 |
Why?
|
| Pseudogenes | 1 | 2013 | 50 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2013 | 57 | 0.020 |
Why?
|
| Software | 1 | 2018 | 736 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2022 | 5085 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 151 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2013 | 191 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2013 | 217 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2013 | 191 | 0.020 |
Why?
|
| Adult | 1 | 2013 | 31204 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2013 | 1228 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 824 | 0.020 |
Why?
|
| Animals | 1 | 2010 | 33897 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 940 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 1728 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 2306 | 0.020 |
Why?
|